Loading...
Loading...
Athersys
ATHX shares tumbled 55.99% to $1.20 on failed trial results for ulcerative colitis.
OncoGenex Pharmaceuticals
OGXI dipped 53.61% to $4.50 after the company and Teva Pharmaceutical Industries
TEVA offered top-line survival results of the Phase III SYNERGY trial for combo with first-line docetaxel/prednisone therapy.
Eltek
ELTK declined 19.87% to $1.73 after the company reported Q4 earnings of $0.39 per share on revenue of $12.70 million.
POZEN
POZN declined 15.66% to $7.70 following Friday's Complete Response Letter from the FDA.
New Oriental Education & Technology Group
EDU shares dropped 11.35% to $23.03 after the company reported FQ3 results. New Oriental's quarterly net income surged 50.2% y/y to US$42.1 million versus US$28.0 million.
Sohu.com
SOHU fell 7.91% to $53.41 after the company reported a Q1 adjusted loss of $1.26 per share on revenue of $365.0 million.
Newmont Mining
NEMLoading...
Loading...
shares slipped 6.01% to $24.86 after the company terminated its merger talks with Barrick Gold
ABX.
Bank of America
BAC shares slipped 4.83% to $15.18 following news from the company the Board will be suspending the previously announced capital actions and resubmit the 2014 capital plan.
Mylan
MYL tumbled 4.15% to $49.94 after Meda's board rejected Mylan proposal.
Changyou.com
CYOU shares slipped 3.94% to $25.60 after the company reported a Q1 loss $0.37 per share on revenue of $180.80 million.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in